entertainment -WSS

entertainment

author：leisure time 2025-09-27 16:23:27 - browse：9486

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Why we need to separate burnout from moral injury in health care

hotspot

WSS

Lawsuit alleges UnitedHealth Group unit illegally denied claims

National panel will explore requiring free Covid tests

New safety details link Apellis eye drug to rare cases of blindness

Gene therapy has helped boys walk. Can scientists keep it that way?

Disclosing genetic information: not as worrisome as once feared

What the airline industry can learn from medicine

explore

entertainment

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

WATCH: Why do fingernails fall off when they're damaged?

Alkermes shareholders re

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The strategy behind pharma's lawsuits over drug pricing reform

Drug repurposing or repositioning? The language matters

Donald Trump's relentless attacks on special counsel Jack Smith

Hollywood unions extend contract negotiations for actors

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Wikipedia

The story of mRNA: From a loose idea to a tool that may help curb Covid

#NeedHerScience: shining a light on gender disparities in medicine

Why are elite athletes different? Take a look at their microbes

What to expect as Trump is arraigned on his Jan 6. indictment

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Gene therapy has helped boys walk. Can scientists keep it that way?

hotspot

Wikipedia

Wikipedia

hotspot